Noboru Shoji
- Molecular Biology
- Pharmacology top 2%
- Organic Chemistry top 10%
- Plant Science top 10%
- Biotechnology top 2%
- Co-authors
- Akemi UmeyamaYasushi OhizumiShigenobu AriharaTSUNEMATSU TAKEMOTOMasao TakeiTsunematsu TakemotoKyosuke NomotoYusuke Ishida
- Topics
- Marine Sponges and Natural Products (12 papers)Natural product bioactivities and synthesis (8 papers)Immunotherapy and Immune Responses (6 papers)
- Cited by
- PharmacologyBiotechnologyToxicology
- Journals
- Journal of Biological ChemistryBiochemical and Biophysical Research CommunicationsJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- JapanGermanySouth Korea
In The Last Decade
Noboru Shoji
50 papers receiving 967 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 398
- Pharmacology 261
- Organic Chemistry 216
- Plant Science 216
- Biotechnology 210
Countries citing papers authored by Noboru Shoji
This map shows the geographic impact of Noboru Shoji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noboru Shoji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noboru Shoji more than expected).
Fields of papers citing papers by Noboru Shoji
This network shows the impact of papers produced by Noboru Shoji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noboru Shoji. The network helps show where Noboru Shoji may publish in the future.
Co-authorship network of co-authors of Noboru Shoji
This figure shows the co-authorship network connecting the top 25 collaborators of Noboru Shoji. A scholar is included among the top collaborators of Noboru Shoji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noboru Shoji. Noboru Shoji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 8 | |
| 3 | 4 | |
| 4 | 8 | |
| 5 | 3 | |
| 6 | 4 | |
| 7 | 10 | |
| 8 | 28 | |
| 9 | 16 | |
| 10 | 20 | |
| 11 | 22 | |
| 12 | 18 | |
| 13 | 1 | |
| 14 | 22 | |
| 15 | 22 | |
| 16 | 11 | |
| 17 | 55 | |
| 18 | 25 | |
| 19 | 14 | |
| 20 | 0 |
About Noboru Shoji
Noboru Shoji is a scholar working on Biotechnology, Pharmacology and Applied Microbiology and Biotechnology, having authored 53 papers that have together received 1.0k indexed citations. Recurring topics across this work include Marine Sponges and Natural Products (12 papers), Natural product bioactivities and synthesis (8 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Pharmacology (261 citations), Biotechnology (210 citations) and Toxicology (60 citations). Noboru Shoji has collaborated with scholars based in Japan, Germany and South Korea. Frequent co-authors include Akemi Umeyama, Yasushi Ohizumi, Shigenobu Arihara, TSUNEMATSU TAKEMOTO, Masao Takei, Tsunematsu Takemoto, Kyosuke Nomoto, Yusuke Ishida, Kazuko Yoshikawa and Toshihiro Hashimoto. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.